• OPEN AN ACCOUNT
Indian Indices
Nifty
23,559.95 -43.40
(-0.18%)
Sensex
77,860.19 -197.97
( -0.25%)
Bank Nifty
50,158.85 -223.25
( -0.44%)
Nifty IT
42,921.65 -99.30
( -0.23%)
Global Indices
Nasdaq
19,523.40 -268.59
(-1.36%)
Dow Jones
44,303.40 -444.23
(-0.99%)
Hang Seng
21,133.54 241.92
(1.16%)
Nikkei 225
38,787.02 -279.51
(-0.72%)
Forex
USD-INR
87.56 0.27
(0.31%)
EUR-INR
90.74 -0.05
(-0.06%)
GBP-INR
108.82 -0.31
(-0.28%)
JPY-INR
0.58 0.01
(1.17%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
360.7381913
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
25.55
118905.02
EPS(TTM)
Face Value()
Div & Yield %
57.63
2
0.88
 

Cipla to invest further Rs 26 cr in Achira Labs
May 15,2024
Cipla has entered into definitive agreements on 15 May 2024 for further investment of upto Rs 26 crore in Achira Labs, an associate company.

The follow-on investment shall strengthen Cipla's partnership with Achira, enabling penetration into business domain of designing, developing and manufacturing microfluidics based PoC immunoassay and molecular assay technologies.